Table 2 Demographics of the 88 CMV seropositive (R+) lung transplant recipients
Characteristics | Oral ganciclovir 3 months | Valganciclovir 3 months |
|---|---|---|
(n = 37) | (n = 51) | |
LTx, years | 2001-2003 | 2004-2006 |
Recipient age years, mean (range) | 49 (15-64) | 52 (13-67) |
Female (%) | 68 | 63 |
Donor age years, mean (range) | 40 (11-61) | 42 (5-70) |
Female (%) | 51 | 57 |
CMV + (%) | 81 | 71 |
Tx type (%) | ||
-Single | 78 | 71 |
-Double | 19 | 29 |
-Heart and lung | 3 | 0 |
Pre-transplant diagnosis (%) | ||
-COPD | 41 | 37 |
-A1AT | 24 | 16 |
-IPF | 19 | 25 |
-CF | 5 | 2 |
-PAH | 3 | 6 |
-Eisenmenger syndrome | 3 | 0 |
-Sarcoidosis | 3 | 0 |
-GVHD | 3 | 4 |
-Scleroderma | 0 | 6 |
-Pulmonary embolism | 0 | 4 |